Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021;15(1):14-22.
doi: 10.1007/s13206-021-00004-5. Epub 2021 Feb 15.

Multiplex Molecular Point-of-Care Test for Syndromic Infectious Diseases

Affiliations
Review

Multiplex Molecular Point-of-Care Test for Syndromic Infectious Diseases

Hanbi Kim et al. Biochip J. 2021.

Abstract

Point-of-care (POC) molecular diagnostics for clinical microbiology and virology has primarily focused on the detection of a single pathogen. More recently, it has transitioned into a comprehensive syndromic approach that employs multiplex capabilities, including the simultaneous detection of two or more pathogens. Multiplex POC tests provide higher accuracy to for actionable decisionmaking in critical care, which leads to pathogen-specific treatment and standardized usages of antibiotics that help prevent unnecessary processes. In addition, these tests can be simple enough to operate at the primary care level and in remote settings where there is no laboratory infrastructure. This review focuses on state-of-the-art multiplexed molecular point-of-care tests (POCT) for infectious diseases and efforts to overcome their limitations, especially related to inadequate throughput for the identification of syndromic diseases. We also discuss promising and imperative clinical POC approaches, as well as the possible hurdles of their practical applications as front-line diagnostic tests.

Keywords: Molecular diagnosis; Multiplex molecular point-of-care testing; POCT; Syndromic infectious disease.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestNo potential conflicts of interest relevant to this article were reported.

Figures

Fig. 1
Fig. 1
Clinical diagnosis of infection according to a diagnostic platform. The implementation of a multiplex point-of-care (POC) test reduces diagnostic cycles for faster and better treatment decisions
Fig. 2
Fig. 2
Integrated molecular diagnostic assay-based microfluidic devices. a SIMPLE chip for blood sample prep, simultaneous digital amplification, and quantitative nucleic acid testing with minimal handling and no-power source. b A foldable all-in-one microdevice for the entire process of multiplex pathogen molecular test by a folding and stacking motion. c Polarized anisotropy diagnostics (PAD) system for the detection of bacterial total RNA. (a From Lee, L.P. et al., Sci Adv 2017, 3 (3), e1501645 under open access license CC BY-NC, reprinted with permission from AAAS/b Reprinted from Lee, N. Y. et al., Sens. Actuators B Chem 2020, 314, 128,057. Copyright by Elsevier/ (C) From Lee, H. et al., Sci Adv 2016, 2 (5), e1600300 under open access license CC BY-NC, Reprinted with permission AAAS)

Similar articles

Cited by

References

    1. de la Fuente-Nunez C, Torres MD, Mojica FJ, Lu TK. Next-generation precision antimicrobials: towards personalized treatment of infectious diseases. Curr. Opin. Microbiol. 2017;37:95–102. doi: 10.1016/j.mib.2017.05.014. - DOI - PMC - PubMed
    1. Mack MR, Kim BS. A precision medicine-based strategy for a severe adverse drug reaction. Nat. Med. 2020;26:167–168. doi: 10.1038/s41591-020-0756-0. - DOI - PubMed
    1. Zhou J, Kroll AV, Holay M, Fang RH, Zhang L. Biomimetic nanotechnology toward personalized vaccines. Adv. Mater. 2020;32:e1901255. doi: 10.1002/adma.201901255. - DOI - PMC - PubMed
    1. Garzon V, Bustos RHDGP. Personalized medicine for antibiotics: the role of nanobiosensors in therapeutic drug monitoring. J. Pers. Med. 2020;10:147. doi: 10.3390/jpm10040147. - DOI - PMC - PubMed
    1. Tyler J, Choi SW, Tewari M. Real-time, personalized medicine through wearable sensors and dynamic predictive modeling: a new paradigm for clinical medicine. Curr. Opin. Syst. Biol. 2020;20:17–25. doi: 10.1016/j.coisb.2020.07.001. - DOI - PMC - PubMed

LinkOut - more resources